These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23342871)

  • 1. [Onset of Crohn's disease induced by etanercept therapy: a case report].
    Mrabet D; Selmi A; Filali A; Sahli H; Sellami S
    Rev Med Liege; 2012 Dec; 67(12):619-22. PubMed ID: 23342871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept.
    Song IH; Appel H; Haibel H; Loddenkemper C; Braun J; Sieper J; Rudwaleit M
    J Rheumatol; 2008 Mar; 35(3):532-6. PubMed ID: 18203308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Crohn's disease following anti-tumour necrosis factor therapy (etanercept).
    Yazisiz V; Avci AB; Erbasan F; Yildirim B; Terzioğlu E
    Colorectal Dis; 2008 Nov; 10(9):953-4. PubMed ID: 18294265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of Crohn's disease during treatment with the anti-tumor necrosis factor agent etanercept for ankylosing spondylitis: possible mechanisms of action.
    Haraoui B; Krelenbaum M
    Semin Arthritis Rheum; 2009 Dec; 39(3):176-81. PubMed ID: 18706681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: case report and review of 142 cases.
    Famenini S; Wu JJ
    J Drugs Dermatol; 2013 Aug; 12(8):939-43. PubMed ID: 23986169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological treatment of ankylosing spondylitis].
    Freiesleben S; Schou M
    Ugeskr Laeger; 2008 Jun; 170(24):2140-5. PubMed ID: 18565298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risks and side effect reactions during therapy with TNF-alpha blockers. An immunologic analysis].
    Berg PA
    Dtsch Med Wochenschr; 2004 Jul; 129(30):1631-4. PubMed ID: 15257503
    [No Abstract]   [Full Text] [Related]  

  • 8. Manifestation of Crohn's disease in a young woman during the course of treatment for severe form of chronic plaque psoriasis with etanercept.
    Tichy M; Hercogova J
    Dermatol Ther; 2014; 27(4):211-4. PubMed ID: 24548537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept: new indication. For ankylosing spondylitis: another option.
    Prescrire Int; 2005 Jun; 14(77):92-3. PubMed ID: 15981387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crohn's disease unmasked following etanercept treatment for ankylosing spondylitis.
    Jethwa H; Mann S
    BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23813506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of etanercept in ankylosing spondylitis.
    Davis JC
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S111-5. PubMed ID: 12463459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis.
    Calin A; Dijkmans BA; Emery P; Hakala M; Kalden J; Leirisalo-Repo M; Mola EM; Salvarani C; Sanmartí R; Sany J; Sibilia J; Sieper J; van der Linden S; Veys E; Appel AM; Fatenejad S
    Ann Rheum Dis; 2004 Dec; 63(12):1594-600. PubMed ID: 15345498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents.
    Braun J; Baraliakos X; Listing J; Davis J; van der Heijde D; Haibel H; Rudwaleit M; Sieper J
    Arthritis Rheum; 2007 May; 57(4):639-47. PubMed ID: 17471540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept (enbrel)-associated inflammatory eye disease: case report and review of the literature.
    Taban M; Dupps WJ; Mandell B; Perez VL
    Ocul Immunol Inflamm; 2006 Jun; 14(3):145-50. PubMed ID: 16766397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies targeting tumor necrosis factor in Crohn's disease.
    Sandborn WJ
    Acta Gastroenterol Belg; 2001; 64(2):170-2. PubMed ID: 11475128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse effects of infliximab and etanercept on T lymphocytes.
    Sieper J; Van Den Brande J
    Semin Arthritis Rheum; 2005 Apr; 34(5 Suppl1):23-7. PubMed ID: 15852251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology.
    Keat A; Barkham N; Bhalla A; Gaffney K; Marzo-Ortega H; Paul S; Rogers F; Somerville M; Sturrock R; Wordsworth P;
    Rheumatology (Oxford); 2005 Jul; 44(7):939-47. PubMed ID: 15901904
    [No Abstract]   [Full Text] [Related]  

  • 18. Etanercept therapy-associated acute uveitis: a case report and literature review.
    Wang F; Wang NS
    Clin Exp Rheumatol; 2009; 27(5):838-9. PubMed ID: 19917170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor necrosis factor-induced neutropenia: a case report with double positive rechallenges.
    Montané E; Sallés M; Barriocanal A; Riera E; Costa J; Tena X
    Clin Rheumatol; 2007 Sep; 26(9):1527-9. PubMed ID: 17031483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible heart failure in a patient receiving etanercept for ankylosing spondylitis.
    Castro Rocha FA; Silva FS
    J Clin Rheumatol; 2010 Mar; 16(2):81-2. PubMed ID: 20130478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.